Clinical Trial Update: Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cisplatin, irinotecan, and radiation therapy for resectable esophageal cancer or gastroesophageal junction cancer. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-03-15